MiR-377-3p inhibits cell metastasis and epithelial-mesenchymal transition in cervical carcinoma through targeting SGK3

被引:4
|
作者
Zhang, X-Y [1 ]
Dong, X-M [2 ]
Wang, F-P [1 ]
机构
[1] Xianyang Cent Hosp, Dept Gynaecol, Xianyang, Peoples R China
[2] Xianyang Cent Hosp, Lab Med, Xianyang, Peoples R China
关键词
Cervical carcinoma; MiR-377-3p; Epithelial-to-mesenchymal transition; Metastasis; Prognosis; SGK3; SUPPRESSES TUMOR-GROWTH; GASTRIC-CANCER; PROLIFERATION; INVASION; MIGRATION; EXPRESSION; PROMOTES; EMT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: In cervical carcinoma (CC), microRNAs (miRNAs) were reported to be involved in its development. In this study, we explored how miR-377-3p regulates cell metastasis and epithelial-mesenchymal transition (EMT) in CC. PATIENTS AND METHODS: Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR), Dual-Luciferase Assay, transwell assays, and Western blot analysis were performed to explore the dysregulation of miR-377-3p. RESULTS: MiR-377-3p expression was decreased in CC, and the downregulation of miR377-3p could predict poor prognosis in CC patients. Moreover, miR-377-3p overexpression repressed cell invasion and migration in CC. Similarly, miR-377-3p overexpression also inhibited EMT in CC cells. Furthermore, miR-377-3p directly targeted SGK3 in CC cells. SGK3 silence had the same function as miR-377-3p overexpression in CC. Especially, the upregulation of SGK3 abolished the inhibitory action of miR-3773p in CC. CONCLUSIONS: Taken together, miR-377-3p inhibited cell metastasis and EMT by suppressing SGK3 expression. Moreover, the high miR377-3p expression could predict good prognosis of CC patients.
引用
收藏
页码:4687 / 4696
页数:10
相关论文
共 50 条
  • [11] MiR-376a functions as tumor suppressor by targeting SGK3 in renal cell carcinoma
    Fan, X-R
    Zhang, Z-Y
    Wang, R-H
    Li, Y.
    Mao, Q-Z
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (09) : 3726 - 3732
  • [12] Effects of miR-106b-3p on cell proliferation and epithelial-mesenchymal transition, and targeting of ZNRF3 in esophageal squamous cell carcinoma
    Qiao, Guanen
    Dai, Chenguang
    He, Yang
    Shi, Junjie
    Xu, Chunfang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 43 (04) : 1817 - 1829
  • [13] MiR-29c-3p inhibits epithelial-mesenchymal transition to inhibit the proliferation, invasion and metastasis of cervical cancer cells by targeting SPARC
    Zou, Ting
    Gao, Yan
    Qie, Mingrong
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (02)
  • [14] miR-144-3p inhibited the growth, metastasis and epithelial-mesenchymal transition of colorectal adenocarcinoma by targeting ZEB1/2
    Li, Taiyuan
    Tan, Cheng
    Huang, Zhixiang
    Yang, Lingling
    Dai, Hua
    Tang, Bo
    Xiao, Benping
    Li, Jianfeng
    Lei, Xiong
    AGING-US, 2021, 13 (13): : 17349 - 17369
  • [15] LncRNA SNHG1 promotes cell progression and metastasis via sponging miR-377-3p in hepatocellular carcinoma
    Qu, A.
    Yang, Q.
    NEOPLASMA, 2020, 67 (03) : 557 - 566
  • [16] MiR-105 inhibits gastric cancer cells metastasis, epithelial-mesenchymal transition by targeting SOX9
    Shang, J-C
    Yu, G-Z
    Ji, Z-W
    Wang, X-Q
    Xia, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (14) : 6160 - 6169
  • [17] miR-214-3p inhibits epithelial-to-mesenchymal transition and metastasis of endometrial cancer cells by targeting TWIST1
    Fang, Yuan-Yuan
    Tang, Ming-Rong
    Zhou, Jian
    Liang, Li
    Liu, Xiao-Yun
    Zhao, Kun
    Bao, Er-Chen
    ONCOTARGETS AND THERAPY, 2019, 12 : 9449 - 9458
  • [18] miR-146a-5p mediates epithelial-mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2
    Wang, Cong
    Zhang, Wenxue
    Zhang, Lin
    Chen, Xuan
    Liu, Fang
    Zhang, Jing
    Guan, Shanghui
    Sun, Yi
    Chen, Pengxiang
    Wang, Ding
    Nesa, Effat Un
    Cheng, Yufeng
    Yousef, George M.
    BRITISH JOURNAL OF CANCER, 2016, 115 (12) : 1548 - 1554
  • [19] Scorpion inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma
    Yan, Yi-Quan
    Xie, Juan
    Wang, Jing-Fu
    Shi, Zhao-Feng
    Zhang, Xiang
    Du, Yong-Ping
    Zhao, Xing-Cheng
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2018, 243 (07) : 645 - 654
  • [20] MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2
    Zhu, Wei
    Luo, Xuewen
    Fu, Hui
    Liu, Lijian
    Sun, Pingliang
    Wang, Zhiguang
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (10)